BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2016 9:54:00 AM | Browse: 900 | Download: 1336
Publication Name World Journal of Clinical Cases
Manuscript ID 23291
Country/Territory Japan
Received
2015-11-07 13:10
Peer-Review Started
2015-11-09 09:49
To Make the First Decision
2015-12-18 11:38
Return for Revision
2015-12-21 13:58
Revised
2016-01-12 17:11
Second Decision
2016-01-22 15:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-01-31 14:35
Articles in Press
2016-01-31 14:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-03 18:51
Publish the Manuscript Online
2016-03-11 09:54
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus
Manuscript Source Unsolicited Manuscript
All Author List Ken Sato, Yuichi Yamazaki, Tatsuya Ohyama, Takeshi Kobayashi, Norio Horiguchi, Satoru Kakizaki, Motoyasu Kusano and Masanobu Yamada
Funding Agency and Grant Number
Corresponding Author Ken Sato, MD, PhD, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. satoken@gunma-u.ac.jp
Key Words Hepatitis C; Oral drug; Daclatasvir; Asuna­previr; Dialysis
Core Tip Oral combination therapy with the direct-acting antiviral agents daclatasvir and asunaprevir, which are both metabolized largely in the liver, is a very useful strategy for dialysis patients infected with genotype 1b hepatitis C virus. Although there were only 4 dialysis patients, the combination therapy was effective and showed a relatively favorable safety profile. One patient was admitted for heart failure with or without pneumonitis and percutaneous coronary intervention, although the causal relationship between these adverse events and the combination therapy was interpreted as negative. Our case reports warrant further studies, although careful observation during the treatment is needed.
Publish Date 2016-03-11 09:54
Citation Sato K, Yamazaki Y, Ohyama T, Kobayashi T, Horiguchi N, Kakizaki S, Kusano M, Yamada M. Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus. World J Clin Cases 2016; 4(3): 88-93
URL http://www.wjgnet.com/2307-8960/full/v4/i3/88.htm
DOI http://dx.doi.org/10.12998/wjcc.v4.i3.88
Full Article (PDF) WJCC-4-88.pdf
Full Article (Word) WJCC-4-88.doc
Manuscript File 23291-Review.docx
Answering Reviewers 23291-Answering reviewers.pdf
Audio Core Tip 23291-Audio core tip.MP3
Conflict-of-Interest Disclosure Form 23291-Conflict-of-interest statement.pdf
Copyright License Agreement 23291-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s) Informed_Consent_Statement_20151106210839.pdf
Institutional Review Board Approval Form or Document 23291-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 23291-Language certificate.pdf
Peer-review Report 23291-Peer-review(s).pdf
Scientific Misconduct Check 23291-Scientific misconduct check.pdf
Scientific Editor Work List 23291-Scientific editor work list.pdf